Chiral thioethers have attracted significant attention in the pharmaceutical industry because of their unique biological properties, which show promise for various therapeutic uses. As molecules with a sulfur atom bonded to two carbon atoms, thioethers have a chiral center when one or more of the groups attached to sulfur are asymmetrical, resulting in the formation of enantiomers. The chirality of these compounds is especially important in pharmacology, as enantiomers of chiral molecules often have different biological activities, with one enantiomer potentially being more effective or causing fewer side effects than the other. This characteristic makes chiral thioethers essential in drug design and development, where their ability to selectively bind to biological targets can be optimized for therapeutic goals. Their sulfur content also enables the modulation of metabolic stability and solubility, which are key factors in improving drug effectiveness. As a result, exploring chiral thioethers as core components or intermediates in drug synthesis has opened new opportunities for developing pharmaceuticals that target a broad range of diseases, from bacterial infections to cancer. These chiral thioethers serve as pivotal intermediates in the synthesis of complex pharmaceutical compounds, offering versatile pathways for the production of stereochemically defined molecules. Their ability to form strong covalent bonds and engage in various chemical reactions, such as oxidation and substitution, enables chemists to manipulate them in ways that facilitate the creation of particular drug molecules. In drug manufacturing, the ability to precisely control the stereochemistry of a molecule is crucial, as even minor alterations in a drug’s three-dimensional structure can significantly affect its function and interactions with biological systems. Chiral thioethers offer a reliable means of achieving this level of precision, and their [361]. As the demand for new and more effective medications continues to grow, the role of chiral thioethers in drug development is expected to expand, providing further opportunities to harness their unique properties in the quest for innovative therapeutic solutions [23, 362–367].